NCT06668987View on ClinicalTrials.gov

A Study of the Boron Neutron Capture Therapy (BNCT) Using B10 L-BPA in Recurrent Meningioma

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 14, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2026

Conditions
MeningiomaBoron Neutron Capture Therapy
Interventions
DRUG

B10 L-BPA Injection

The investigational product is B10 L-BPA Injection, is a boron-containing compound in which 10B replaces a position on L-phenylalanine at the para position with dihydroxyboron.

Trial Locations (1)

Unknown

Taipei Veterans General Hsopital, Taipei

All Listed Sponsors
lead

Heron Neutron Medical Corp.

INDUSTRY

NCT06668987 - A Study of the Boron Neutron Capture Therapy (BNCT) Using B10 L-BPA in Recurrent Meningioma | Biotech Hunter | Biotech Hunter